Cerity Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Sell |
12,292
-4,993
| -29% | -$1.24M | ﹤0.01% | 1242 |
|
|
2025
Q4 | $4.76M | Buy |
17,285
+2,993
| +21% | +$819K | 0.01% | 948 |
|
|
2025
Q3 | $3.75M | Buy |
14,292
+5,519
| +63% | +$1.34M | 0.01% | 1004 |
|
|
2025
Q2 | $1.92M | Buy |
8,773
+5,742
| +189% | +$1.23M | ﹤0.01% | 1238 |
|
|
2025
Q1 | $679K | Sell |
3,031
-2,353
| -44% | -$648K | ﹤0.01% | 1605 |
|
|
2024
Q4 | $1.65M | Buy |
5,384
+90
| +2% | +$28.3K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $1.59M | Buy |
5,294
+2,566
| +94% | +$786K | ﹤0.01% | 1192 |
|
|
2024
Q2 | $899K | Sell |
2,728
-2,915
| -52% | -$1.03M | ﹤0.01% | 1274 |
|
|
2024
Q1 | $2.23M | Buy |
5,643
+3,902
| +224% | +$1.44M | 0.01% | 923 |
|
|
2023
Q4 | $613K | Buy |
1,741
+539
| +45% | +$191K | ﹤0.01% | 1187 |
|
|
2023
Q3 | $451K | Sell |
1,202
-487
| -29% | -$188K | ﹤0.01% | 1017 |
|
|
2023
Q2 | $646K | Buy |
1,689
+288
| +21% | +$103K | ﹤0.01% | 1082 |
|
|
2023
Q1 | $485K | Sell |
1,401
-373
| -21% | -$109K | ﹤0.01% | 1301 |
|
|
2022
Q4 | $418K | Buy |
1,774
+912
| +106% | +$216K | ﹤0.01% | 1021 |
|
|
2022
Q3 | $213K | Buy |
862
+111
| +15% | +$33.8K | ﹤0.01% | 1034 |
|
|
2022
Q2 | $227K | Buy |
+751
| New | +$244K | ﹤0.01% | 1030 |
|
|
2021
Q3 | – | Sell |
-709
| Closed | -$255K | – | 728 |
|
|
2021
Q2 | $255K | Sell |
709
-2
| -0.3% | -$661 | 0.01% | 630 |
|
|
2021
Q1 | $200K | Buy |
+711
| New | +$203K | ﹤0.01% | 665 |
|
|
2019
Q2 | – | Sell |
-2,787
| Closed | -$307K | – | 585 |
|
|
2019
Q1 | $307K | Buy |
2,787
+288
| +12% | +$30K | 0.02% | 416 |
|
|
2018
Q4 | $245K | Buy |
2,499
+770
| +45% | +$83.5K | 0.02% | 444 |
|
|
2018
Q3 | $213K | Buy |
+1,729
| New | +$194K | 0.01% | 503 |
|
Other funds holding WST
VCM
VPM
GIM
